Xeris Pharmaceuticals (XERS) PT Raised to $7 at Oppenheimer
Tweet
Share
E-mailGet Alerts XERS Hot Sheet
Price: $8.53 -0.7%
Rating Summary:
7 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
7 Buy, 1 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Oppenheimer analyst Leland Gershell raised the price target on Xeris Pharmaceuticals (NASDAQ: XERS) to $7.00 (from $6.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Snowflake Inc. (SNOW) PT Raised to $450 at Freedom Broker
- Equity Bancshares (EQBK) PT Raised to $59 at StoneX
- Mama’s Creations (MAMA) PT Lowered to $22 at DA Davidson Following Q2 Beat
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
